Researchers Identify Circadian Depression as a Distinct Subtype Affecting Millions
Australian researchers have identified circadian depression as a new subtype affecting nearly a quarter of severe cases. Linked to the body clock, it resists standard SSRIs but responds better to light therapy and melatonin.
Researchers at the University of Sydney have identified a distinct subtype of depression known as circadian depression, which accounts for nearly a quarter of severe, recurrent, or persistent cases. The study utilized clinical and genetic data from more than 10,000 Australians to uncover how this form is linked to the body's internal biological clock that regulates sleep-wake cycles.
Clinical Characteristics and Treatment Resistance
Circadian depression is characterized by a higher resistance to conventional serotonin-based antidepressant medications, such as SSRIs and SNRIs. However, it shows greater responsiveness to targeted behavioral and medical treatments that focus on the brain's clock circuits, including melatonin, melatonin-targeted antidepressants, and light therapy.
Lead author Dr. Emiliana Tonini from the Brain and Mind Centre noted that depression is not a uniform illness, and identifying specific subtypes allows patients to receive the most effective treatments much earlier. The study found that approximately 25 percent, or 2,604 participants, suffered from circadian depression, exhibiting symptoms such as seasonal patterns, prolonged sleep during depressive episodes, morning fatigue, and nocturnal hyperactivity.
Genetic Risks and Early Intervention
Individuals with circadian depression tended to experience onset earlier in life and presented with more severe symptoms, including higher rates of mania and suicidal ideation. Furthermore, they demonstrated an elevated genetic risk for inflammatory conditions, cardiovascular issues, and neurodevelopmental disorders such as ADHD.
Senior author Dr. Jacob Crouse emphasized that because circadian depression is tied to the body clock, treatments targeting circadian rhythms should be considered much earlier by physicians. Co-author Professor Ian Hickie warned that failing to recognize this subtype in young people has frequently led to early treatment failures and adverse side effects, highlighting the urgent need for tailored therapeutic approaches.
